Key result
The ALOX5AP HapA haplotype was not associated with stroke risk.
Why the study?
Do ALOX5AP gene variants increase the risk of stroke?
Meta-Analysis (n=9,760)
Do ALOX5AP gene variants increase the risk of stroke?
This meta-analysis found insufficient evidence to confirm a significant association between ALOX5AP gene variants and the risk of stroke.
Answers are grounded in this paper and cite their sources.
Does not support ALOX5AP HapA as a stroke risk factor; leaves open contributions from other variants or populations.
Variants of the arachidonate 5-lipoxygenase-activating protein (ALOX5AP) gene have been implicated as a risk factor for stroke. However, genetic association studies that have examined the association between ALOX5AP gene variants (HapA haplotype, HapB haplotype, and SG polymorphisms) and stroke have produced conflicting results. Therefore, the authors performed a meta-analysis of all studies with ALOX5AP genotyping (5,194 stroke cases and 4,566 controls). The meta-analysis showed significant heterogeneity among studies (P(Q) = 0.03, I(2) = 63%) and a nonsignificant association between the HapA haplotype (SG13S25G-SG13S114T-SG13S89G-SG13S32A) and stroke risk (random-effects (RE) odds ratio (OR) = 1.13, 95% confidence interval (CI): 0.88, 1.45). Regarding the HapB haplotype (SG13S377A-SG13S114A-SG13S41A-SG13S35G), there was no association with stroke risk (RE OR = 1.03, 95% CI: 0.77, 1.37). The SG13S114, SG13S89, SG13S25, SG13S32, SG13S35, and SG13S42 polymorphisms were not associated with stroke. The SG13S106 and SG13S377 polymorphisms revealed evidence of marginal association (RE OR = 1.23 (95% CI: 1.03, 1.46) and RE OR = 1.25 (95% CI: 1.04, 1.50), respectively). However, cumulative meta-analysis for the HapA haplotype showed a downward trend of odds ratios over time, and recursive cumulative meta-analysis indicated insufficient evidence for claiming or denying an association. Tests for bias revealed no evidence of biases. Rigorous genetic association studies investigating gene-gene-environment interactions may generate more conclusive claims about the genetics of stroke.
No takes yet. Share an insight, caveat, or question.
Ζιντζαράς et al. (2009) conducted a meta-analysis in Stroke (n=9,760). ALOX5AP gene variants (HapA haplotype) vs. Controls was evaluated on Stroke risk (OR 1.13, 95% CI 0.88, 1.45). The ALOX5AP HapA haplotype was not associated with stroke risk.
Synapse has enriched 10 related papers. Consider them for comparative context: